Novel 3,4-diazabenzotropone compounds (2,3-benzodiazepin-5-ones): Synthesis, unique reactivity, and biological evaluation

Organic Letters

Volumn 11, Issue 6, 2009, Pages 1361-1364

  Matsuya, Yuji ^a   Katayanagi, Hiroshi ^a   Ohdaira, Takuya ^a   Wei, Zheng Li ^a   Kondo, Takashi ^a   Nemoto, Hideo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; TROPOLONE; TROPONE;

APOPTOSIS; ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG EFFECT; DRUG SCREENING; HUMAN; SYNTHESIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZODIAZEPINES; CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; TROPOLONE;

EID: 64049093066     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol900154x     Document Type: Article

References (25)

1. For reviews, see: (a) Zappala, M.; Grasso, S.; Micale, N.; Polimeni, S.; De Micheli, C. Mini-Rev. Med. Chem. 2001, 1, 243-253.
2. (b) Solyom, S.; Tarnawa, I. Curr. Pharm. Design 2002, 913-939.
3. For recent examples, see: (a) Zappala, M.; Postorino, G.; Micale, N.; Caccamese, S.; Parrinello, N.; Grazioso, G.; Roda, G.; Menniti, F. S.; De Sarro, G.; Grasso, S. J. Med. Chem. 2006, 49, 575-581.
4. (b) Elger, B.; Huth, A.; Neuhaus, R.; Ottow, E.; Schneider, H.; Seilheimer, B.; Turski, L. J. Med. Chem. 2005, 48, 4618-4627.
5. (c) Gitto, R.; Orlando, V.; Quartarone, S.; De Sarro, G.; De Sarro, A.; Russo, E.; Ferreri, G.; Chimirri, A. J. Med. Chem. 2003, 46, 3758-3761.
6. (d) Szabados, T.; Gigler, G.; Gacsalyi, I.; Gyertan, I.; Levay, G. Brain Res. Bull. 2001, 55, 387-391.
7. Matsuya, Y.; Ohsawa, N.; Nemoto, H. J. Am. Chem. Soc. 2006, 128, 13072-13073.
8. For a recent report on the synthesis of monocyclic 2-azatropone, see: (a) Takami, S.; Oshida, A.; Tawada, Y.; Kashino, S.; Satake, K.; Kimura, M. J. Org. Chem. 2000, 65, 6093-6096. Recently, a diazabicyclic benzotropolone framework has been reported; see:
9. (b) Khrizman, A.; Moulthrop, J. S.; Little, S.; Wharton, H.; Yardley, V.; Moyna, G. Bioorg. Med. Chem. Lett. 2007, 17, 4183-4186.
10. For recent topics on benzotropones, see: (a) Ohkita, M.; Sano, K.; Suzuki, T.; Tsuji, T.; Sato, T.; Niino, H. Org. Biomol. Chem. 2004, 2, 1044-1050.
11. (b) Güney, M.; Dastan, A.; Balci, M. Helv. Chim. Acta 2005, 88, 830-838.
12. (c) Ohkita, M.; Sano, K.; Suzuki, T.; Tsuji, T. Tetrahedron Lett. 2001, 42, 7295-7297.
13. Preparation of these compounds is described in the Supporting Information.
14. The adduct 6 is likely to be stable only in a solution. Attempts to isolate 6 ended in failure because regeneration of the diazepine 4 took place during the isolation process.
15. Recently, decomposition of 1, 2, 3-triazolines with loss of nitrogen to form aziridines has been reported; see: Kim, S.; Lee, Y. M.; Lee, J.; Lee, T.; Fu, Y.; Song, Y.; Cho, J.; Kim, D. J. Org. Chem. 2007, 72, 4886-4891.
16. (a) Reid, A. A.; Sood, H. R.; Sharp, J. T. J. Chem. Soc. Perkin Trans. 1 1976, 362-366.
17. (b) Munro, D. P.; Sharp, J. T. J. Chem. Soc.. Perkin Trans. 1 1980, 1718-1723.
18. (c) Reid, A. A.; Sharp, J. T.; Murray, S. J. J. Chem. Soc.. Chem. Commun. 1972, 827.
19. 4 reduction of 4a (see the Supporting Information), did not participate in the nitrogen extrusion reaction under the optimal conditions.
20. (a) Ahmed, K.; Zhao, Q.-L.; Matsuya, Y.; Yu, D.-Y.; Salunga, T. L.; Nemoto, H.; Kondo, T. Int. J. Hyperthermia 2007, 23, 353-361.
21. (b) Ahmed, K.; Zhao, Q.-L.; Matsuya, Y.; Yu, D.-Y.; Feril, L. B., Jr; Nemoto, H.; Kondo, T. Chem. Biol. Interact. 2007, 170, 86-99.
22. (c) Matsuya, Y.; Kawaguchi, T.; Ishihara, K.; Ahmed, K.; Zhao, Q.-L.; Kondo, T.; Nemoto, H. Org. Lett. 2006, 8, 4609-4612.
23. (a) Griffith, O. W. Anal. Biochem. 1980, 106, 207-212.
24. (b) Baker, M. A.; Cerniglia, G. J.; Zaman, A. Anal. Bio Chem. 1990, 190, 360-365.
25. (c) Vandeputte, C.; Guizon, I.; Genestie-Denis, I.; Vannier, B.; Lorenzon, G. Cell Biol. Toxicol. 1994, 10, 415-421.